The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis
Open accessAbstract
The majority of cystic fibrosis (CF) patients succumb to a chronic infection of the airway with Pseudomonas aeruginosa . Paradoxically, pathogenic strains are often susceptible to antibiotics, but the infection cannot be eradicated with antimicrobial therapy. We find that in a majority of patients with airway infections, late isolates of P. aeruginosa produce increased levels of drug-tolerant persister cells. The genomes of a clonal pair of early/late isolates from a single patient have been previously sequenced, and the late isolate (obtained at age 96 months) showed a 100-fold increase in persister levels. The 96-month isolate carries a large number of mutations, including a mutation in mutS that confers a hypermutator phenotype. There is also a mutation in the mexZ repressor controlling the expression of the MexXY-OprM multidrug pump, which results in a moderate increase in the ofloxacin, carbenicillin, and tobramycin MICs. Knocking out the mexXY locus restored the resistance to that of the parent strain but did not affect the high levels of persisters formed by the 96-month isolate. This suggests that the late isolate is a high-persister ( hip ) mutant. Increased persister formation was observed in exponential phase, stationary phase, and biofilm populations of the 96-month isolate. Analysis of late isolates from 14 additional patients indicated that 10 of them are hip mutants. Most of these hip mutants did not have higher drug resistance. Increased persister formation appears to be their sole mechanism for surviving chemotherapy. Taken together, these findings suggest a link between persisters and recalcitrance of CF infection and identify an overlooked culprit—high-persister mutants producing elevated levels of drug-tolerant cells. Persisters may play a similarly critical role in the recalcitrance of other chronic infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 4×
“An important hallmark of persisters is multidrug tolerance (36).”
BackgroundInfluentialSelf-citationHoang, T. T., Karkhoff-Schweizer, R. R., Kutchma, A. J., & Schweizer, H. P. (1998) · Gene · doi:10.1016/s0378-1119(98)00130-9 · Cited by 1,922
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Self-citationQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Self-citationGene expression in Pseudomonas aeruginosa biofilms
Whiteley, M., Bangera, M. G., Bumgarner, R. E., Parsek, M. R., Teitzel, G. M., Lory, S., & Greenberg, E. P. (2001) · Nature · doi:10.1038/35101627 · Cited by 1,183
Self-citationPersister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,098
Self-citationWalters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Self-citationWhy chronic wounds will not heal: a novel hypothesis
Bjarnsholt, T., Kirketerp‐Møller, K., Jensen, P. Ø., Madsen, K. G., Phipps, R., Krogfelt, K., Høiby, N., & Givskov, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00283.x · Cited by 886
Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 856
Self-citationPseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
Dörr, T., Vulić, M., & Lewis, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000317 · Cited by 782
Self-citationPersisters: a distinct physiological state of E. coli
Shah, D., Zhang, Z., Khodursky, A. B., Kaldalu, N., Kurg, K., & Lewis, K. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-53 · Cited by 629
Self-citationMoyed, H. S., & Bertrand, K. P. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.768-775.1983 · Cited by 625
Vuong, C., Voyich, J. M., Fischer, E. R., Braughton, K. R., Whitney, A. R., DeLeo, F. R., & Otto, M. (2004) · Cellular Microbiology · doi:10.1046/j.1462-5822.2004.00367.x · Cited by 623
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Self-citationTUOMANEN, E., COZENS, R., TOSCH, W., ZAK, O., & TOMASZ, A. (1986) · Microbiology · doi:10.1099/00221287-132-5-1297 · Cited by 477
Gilbert, P., Collier, P. J., & Brown, M. R. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.1865 · Cited by 403
Molecular Mechanisms of HipA-Mediated Multidrug Tolerance and Its Neutralization by HipB
Schumacher, M. A., Piro, K. M., Xu, W., Hansen, S., Lewis, K., & Brennan, R. G. (2009) · Science · doi:10.1126/science.1163806 · Cited by 351 · cited 4×
“iting protein synthesis through phosphorylation of Ef-Tu (42),”
BackgroundInfluentialSelf-citationD'Argenio, D. A., Wu, M., Hoffman, L. R., Kulasekara, H. D., Déziel, E., Smith, E. E., Nguyen, H., Ernst, R. K., Larson Freeman, T. J., Spencer, D. H., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05678.x · Cited by 342
Self-citationChristensen, S. K., & Gerdes, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03512.x · Cited by 338
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-855oc · Cited by 318
Self-citationPseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression
Hoffman, L. R., Kulasekara, H. D., Emerson, J., Houston, L. S., Burns, J. L., Ramsey, B. W., & Miller, S. I. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.006 · Cited by 301
Self-citationPharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis
Geller, D. E., Pitlick, W. H., Nardella, P. A., Tracewell, W. G., & Ramsey, B. W. (2002) · Chest · doi:10.1378/chest.122.1.219 · Cited by 300
Role of Global Regulators and Nucleotide Metabolism in Antibiotic Tolerance in Escherichia coli
Hansen, S., Lewis, K., & Vulić, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00144-08 · Cited by 300
Self-citationSchweizer, H. P. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01558.x · Cited by 295
Davis, B. D., Chen, L. L., & Tai, P. C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6164 · Cited by 293
Burns, J. L., Van Dalfsen, J. M., Shawar, R. M., Otto, K. L., Garber, R. L., Quan, J. M., Montgomery, A. B., Albers, G. M., Ramsey, B. W., & Smith, A. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314727 · Cited by 289
Self-citationContribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Mena, A., Smith, E. E., Burns, J. L., Speert, D. P., Moskowitz, S. M., Perez, J. L., & Oliver, A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01147-08 · Cited by 251
Self-citationPatients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans
LaFleur, M. D., Qi, Q., & Lewis, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-09 · Cited by 237
Self-citationVázquez-Laslop, N., Lee, H., & Neyfakh, A. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.10.3494-3497.2006 · Cited by 231
Alhede, M., Bjarnsholt, T., Jensen, P. O., Phipps, R. K., Moser, C., Christophersen, L., Christensen, L. D., van Gennip, M., Parsek, M., Hoiby, N., et al. (2009) · Microbiology · doi:10.1099/mic.0.031443-0 · Cited by 226
Yang, L., Haagensen, J. A. J., Jelsbak, L., Johansen, H. K., Sternberg, C., Høiby, N., & Molin, S. (2008) · Journal of Bacteriology · doi:10.1128/jb.01581-07 · Cited by 225
Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa
Schaber, J. A., Carty, N. L., McDonald, N. A., Graham, E. D., Cheluvappa, R., Griswold, J. A., & Hamood, A. N. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45617-0 · Cited by 224
Comparative Genomics of the IncA/C Multidrug Resistance Plasmid Family
Fricke, W. F., Welch, T. J., McDermott, P. F., Mammel, M. K., LeClerc, J. E., White, D. G., Cebula, T. A., & Ravel, J. (2009) · Journal of Bacteriology · doi:10.1128/jb.00189-09 · Cited by 219
Harrison, J. J., Turner, R. J., & Ceri, H. (2005) · Environmental Microbiology · doi:10.1111/j.1462-2920.2005.00777.x · Cited by 214
GlpD and PlsB Participate in Persister Cell Formation in Escherichia coli
Spoering, A. L., Vulić, M., & Lewis, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.00369-06 · Cited by 214
Self-citationCooperation and virulence of clinical Pseudomonas aeruginosa populations
Köhler, T., Buckling, A., & van Delden, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811741106 · Cited by 207
Correia, F. F., D'Onofrio, A., Rejtar, T., Li, L., Karger, B. L., Makarova, K., Koonin, E. V., & Lewis, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.01237-06 · Cited by 199
Self-citationA small SOS‐induced toxin is targeted against the inner membrane in Escherichia coli
Unoson, C., & Wagner, E. G. H. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06416.x · Cited by 197
Permeation of Antimicrobial Agents through Pseudomonas aeruginosa Biofilms: A Simple Method
Shigeta, M., Tanaka, G., Komatsuzawa, H., Sugai, M., Suginaka, H., & Usui, T. (1997) · Chemotherapy · doi:10.1159/000239587 · Cited by 187
The Mechanism of Inhibition of Topoisomerase IV by Quinolone Antibacterials
Khodursky, A. B., & Cozzarelli, N. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27668 · Cited by 163
Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening
Groote, V. N. D., Verstraeten, N., Fauvart, M., Kint, C. I., Verbeeck, A., Beullens, S., Cornélis, P., & Michiels, J. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01657.x · Cited by 155
Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis
Conway, S. P., Brownlee, K. G., Denton, M., & Peckham, D. G. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256660 · Cited by 142
Fournier, B., Zhao, X., Lu, T., Drlica, K., & Hooper, D. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2160-2165.2000 · Cited by 133
Wolfson, J. S., Hooper, D. C., McHugh, G., Bozza, M. A., & Swartz, M. N. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.1938 · Cited by 110
King, P. A., Lomovskaya, O., Griffith, D. C., Burns, J. L., & Dudley, M. N. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00248-09 · Cited by 70
Self-citationLiPuma, J. J., Rathinavelu, S., Foster, B. K., Keoleian, J. C., Makidon, P. E., Kalikin, L. M., & Baker, J. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00691-08 · Cited by 57
Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers
Guay, D. R. P., Opsahl, J. A., McMahon, F. G., Vargas, R., Matzke, G. R., & Flor, S. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.308 · Cited by 22
Gilligan, P. H. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.5.711 · Cited by 21
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Self-citationThe Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Self-citation
Metadata
- Authors
- Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K.
- Venue
- Journal of Bacteriology
- Publisher
- American Society for Microbiology
- Published
- 2010-12
- Volume
- 192
- Issue
- 23
- Pages
- 6191-6199
- ISSN
- 0021-9193 (ISSN-L)
- 1098-5530
- OpenAlex
- W2107600014
- Cited by
- 631
- References
- 54
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.